コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 lear factor-kappaB (RANK) ligand (RANKL) and lymphotoxin.
2 een the sets of genes controlled by Aire and lymphotoxin.
3 tromal cells and dendritic cells, partly via lymphotoxin.
4 d increase in CXCL13 was partly mediated via lymphotoxin.
5 zone (MZ) and requires B cells that express lymphotoxin.
6 derived from lymphocytes (20 kDa), was named lymphotoxin.
7 pendent on the chemokine CXCL13, B cells and lymphotoxin.
8 technique and with tumor necrosis factor-308/lymphotoxin + 250 GG haplotype for prolonged mechanical
13 e polymorphism (SNP) haplotype involving the lymphotoxin alpha (LTA) and tumor necrosis factor (TNF)
14 se hypersensitive sites corresponding to the lymphotoxin alpha (LTA) and tumour necrosis factor (TNF)
15 modified by a functional polymorphism in the lymphotoxin alpha (LTA) gene (LTA C+80A, where the CC ge
17 in B cells (lkappaBL), inhibitor-like 1 and lymphotoxin alpha (LTA), in relation to nutritional iron
20 sized the role of type 1 IFN (IFN-alpha) and lymphotoxin alpha (LTalpha) in the pathogenesis of the d
21 tic deletion of lymphotoxin beta receptor or lymphotoxin alpha abrogated development of lymphatic ves
23 model decreased the muscle protein levels of lymphotoxin alpha and Il17a by 32% and 42%, respectively
25 ng wild-type control mice and splenectomized lymphotoxin alpha knockout (LT) mice deficient in SLOs a
26 activation on macrophages by T cell-derived lymphotoxin alpha(1)beta(2) controls proinflammatory res
27 ts and effector molecules (interferon gamma, lymphotoxin alpha, and myxovirus resistance 1) were redu
28 onses, the conventional TNF ligand LIGHT and lymphotoxin alpha, as well as herpes simplex virus glyco
29 king either lymphotoxin beta receptor or the lymphotoxin alpha-chain, and there was minimal overlap b
30 s in infection by and immunity to rotavirus, lymphotoxin alpha-deficient (LTalpha(-/-)) mice that lac
31 ne the role of lymph node in CNV, we lasered lymphotoxin alpha-deficient mice (LTalpha-/-) and measur
32 es of transitional B cells in splenectomized lymphotoxin alpha-deficient mice that lack all secondary
34 ember, BALM, unique to fish; 3) orthologs of lymphotoxins alpha and beta were not clearly identified
37 olymorphisms in the TNF -308G>A (rs1800629), lymphotoxin-alpha (LTA) 252A>G (rs909253), IL10 -3575T>A
40 n separated by sex, a variant in intron 1 of lymphotoxin-alpha (LTA), a gene adjacent to TNF, was ass
41 ndertaken, and the pro-inflammatory cytokine lymphotoxin-alpha (LTA), and its key ligand galectin-2 (
43 udy, we show in vitro that HRS cells secrete lymphotoxin-alpha (LTalpha) which acts on endothelial ce
45 enes, including interferon-gamma (IFNgamma), lymphotoxin-alpha (LTalpha), tumor necrosis factor-alpha
47 t al report that Reed-Sternberg cell-derived lymphotoxin-alpha activates endothelial cells to enhance
50 The tumor necrosis factor gene (TNF) and lymphotoxin-alpha gene (LTA) have long attracted attenti
53 rdiaI infarction with the LTA gene (encoding lymphotoxin-alpha), and a follow-up study found that an
55 e canonical TNF-related cytokines, LIGHT and Lymphotoxin-alpha, and the Ig-related membrane proteins,
57 c variation at the human LTA locus, encoding lymphotoxin-alpha, is associated with susceptibility to
59 ocument a novel link between IL-12Rbeta2 and lymphotoxin-alpha, TNF-alpha, and IFN-gamma expression,
60 vated T cells and impaired overexpression of lymphotoxin-alpha, TNF-alpha, and IFN-gamma in the brain
61 Neutralization of IL-17 in CCR7(-/-) or in lymphotoxin-alpha-deficient animals specifically inhibit
63 CD8(+) RTEs efficiently populated the gut of lymphotoxin-alpha-deficient mice, which lack lymphoid or
67 s the lymphorganogenic cytokines/chemokines, lymphotoxin-alpha/-beta, CCL19, CCL20, CCL21, and CXCL13
68 selectively binds and inhibits TNF/TNFR1 and lymphotoxin-alpha/TNFR1 signaling with good affinity and
69 f SLO microarchitecture; their expression of lymphotoxin alpha1beta2 (LTalpha1beta2) is required for
71 show SCS macrophage development depended on lymphotoxin-alpha1beta2, and the cells had low lysosomal
72 tic anti-LTbR antibody or the natural ligand lymphotoxin-alpha1beta2, increased Ccl5 mRNA expression.
73 port that IL-17 signals synergistically with lymphotoxin-alpha3, using the same signaling motifs with
76 display IL-7-dependent induction of surface lymphotoxin-alphabeta, demonstrating their potential to
78 tionally significant: mice deficient in both lymphotoxin and CD30 (dKO) signals had significantly sma
82 uantitative RT-PCR, and smaller increases in lymphotoxins and TNF receptors that preceded vessel remo
84 by providing tumor-necrosis factor (TNF) and lymphotoxin, and they stimulated MZ B cells via B cell-a
86 Cytokines, including TNF, IFN-gamma, and lymphotoxin, are thought to contribute to its pathogenes
87 fects characteristic of TNF ablation but not lymphotoxin-associated defects characterized by lack of
90 ates liver regeneration via a T cell-derived lymphotoxin axis, and pharmacological stimulation of lym
92 promoter regions, a CpG island in exon 4 of lymphotoxin beta (LTB), the 3' end of nuclear factor of
97 anistically, we show that CD8(+) T cells and lymphotoxin beta are central mediators of HCC formation.
99 eatment with interferon-gamma, which induced lymphotoxin beta receptor (LT beta R) expression, was re
100 implex virus entry mediator (HVEM) and LIGHT/lymphotoxin beta receptor (LT beta R) interactions decre
101 is study demonstrates enhanced expression of lymphotoxin beta receptor (Lt betaR) during the demyelin
104 ediated by at least two receptors, including lymphotoxin beta receptor (LTbetaR) and herpes simplex v
106 eady-state and after bone marrow transplant, lymphotoxin beta receptor (LTbetaR) controls entry of T
108 onditional gene-deficient mice, we find that lymphotoxin beta receptor (LTbetaR) directly controls th
111 (LT)alpha(1)beta(2) on inducer cells and the lymphotoxin beta receptor (LTbetaR) on stromal cells ini
112 fusion protein between the IgG Fc domain and lymphotoxin beta receptor (LTbetaR) reduces lung fibrosi
113 inflammation mediated by LIGHT, a ligand for lymphotoxin beta receptor (LTbetaR), not only stimulates
114 fic deletion of the thymus medulla regulator lymphotoxin beta receptor (LTbetaR), we show that thymic
115 a substantial reduction in the expression of lymphotoxin beta receptor (LTbetaR)-controlled migration
119 nt region of IgG and extracellular domain of lymphotoxin beta receptor (LTbetaRIg) interrupted clonal
121 Induction of PNAd in mutant PPs requires lymphotoxin beta receptor activity, and its upregulation
122 f lymphotoxin was confirmed, as the use of a lymphotoxin beta receptor agonist results in partial res
123 both of its identified signaling receptors, lymphotoxin beta receptor and herpes virus entry mediato
124 rmation was dependent on lymphotoxin and the lymphotoxin beta receptor and independent of lymphocytes
125 LIGHT protected mice from colitis via the lymphotoxin beta receptor and was expressed mainly by my
126 ion of LT and LIGHT signaling with a soluble lymphotoxin beta receptor decoy protein attenuated the d
128 xin axis, and pharmacological stimulation of lymphotoxin beta receptor might represent a novel therap
130 lary epithelial cells of mice lacking either lymphotoxin beta receptor or the lymphotoxin alpha-chain
131 mphangiogenesis in the thyroid and implicate lymphotoxin beta receptor signaling in this process.
132 Notch-dependent Esam(hi) DC subset required lymphotoxin beta receptor signaling, proliferated in sit
133 found that an agonistic antibody against the lymphotoxin beta receptor was able to facilitate liver r
134 tinal inflammation when transferred into the lymphotoxin beta receptor-deficient mice, and herpes vir
139 estingly, both the tumor necrosis factor and lymphotoxin beta receptors were down-regulated by NS5A.
141 is factor superfamily member LIGHT activates lymphotoxin beta-receptor signaling, leading to the prod
142 activated, LTalphabeta(+), lymphocytes with lymphotoxin beta-receptor-expressing fibrosarcoma tumor
151 s and that this loss was caused by decreased lymphotoxin-beta mainly produced by the CD4 T cells.
152 osis factor-alpha (TNF-alpha), whereas decoy lymphotoxin-beta receptor (LT-betaR) fusion protein had
153 ult mice was reduced by systemic blockade of lymphotoxin-beta receptor (LTbeta R) signaling with a so
154 re NIK for activation of NF-kappaB, only the lymphotoxin-beta receptor (LTbeta-R) is expressed in mel
157 ammatory mechanism, including membrane-bound lymphotoxin-beta receptor (LTbetaR) and CXC chemokine re
159 this effect through the interaction with the lymphotoxin-beta receptor (LTbetaR) but not herpes virus
161 Moreover, we show that signals through the lymphotoxin-beta receptor (LTbetaR) in DC are also requi
162 R4-activated canonical NF-kappaB pathway and lymphotoxin-beta receptor (LTbetaR) induced non-canonica
164 equires innate lymphoid cells, which promote lymphotoxin-beta receptor (LTbetaR)-dependent maintenanc
167 SF-14) is a ligand of stromal cell-expressed lymphotoxin-beta receptor and T cell-expressed herpes vi
168 of six single chain-Fv fragments of the anti-lymphotoxin-beta receptor antibody, statistically signif
170 de development during embryogenesis involves lymphotoxin-beta receptor engagement and subsequent diff
171 al-associated lymphoid tissue by LTbetaR-Ig (lymphotoxin-beta receptor human Ig fusion protein) treat
172 nobese diabetic (NOD) mice were treated with lymphotoxin-beta receptor immunoglobulin fusion protein
173 CICD was strongly activated by both TNF and lymphotoxin-beta receptor ligation in IKKbeta-/- MEFs an
174 as well as pharmacological inhibition of the lymphotoxin-beta receptor markedly delays tumor developm
176 on in the thymi of lymphotoxin-deficient and lymphotoxin-beta receptor-deficient mice contributes to
177 ions including BO, and that treatment with a lymphotoxin-beta receptor-immunoglobulin fusion protein
179 (tumor necrosis factor alpha, IL-1beta, and lymphotoxin-beta), and leukocyte genes (S100A9, Aif1/Iba
180 ive CD4 and CD8 T-cell subsets and decreased lymphotoxin-beta, a key factor for maintenance of FRC ne
181 s, which, in turn, removed a major source of lymphotoxin-beta, a survival factor for FRCs during SIV
182 on of lymphoid chemokines CXCL13, CCL19, and lymphotoxin-beta, and is associated with development of
183 tumor necrosis factor (TNF)-alpha, TNF-beta, lymphotoxin-beta, or TNFR1, TNFR2, Fas, or death recepto
184 resembling that observed in B-cell-specific lymphotoxin-beta-deficient mice, including disruption of
185 ated by intragraft TLOs and whether blocking lymphotoxin-beta-receptor (LTbetaR) signaling, a pathway
186 Rather, cell-specific deletion and in vivo lymphotoxin blockade link these systemic autoimmune resp
188 cessible to repeat biopsy, the effect of TNF/lymphotoxin blockade with etanercept (soluble TNFR) was
190 r of the TNF family (BAFF), ICOS ligand, and lymphotoxin, correlated with more well-developed iBALT.
191 he failure of Aire induction in the thymi of lymphotoxin-deficient and lymphotoxin-beta receptor-defi
192 ansfer of splenocytes from wild-type but not lymphotoxin-deficient mice improved liver regeneration i
193 architecture of milky spots was disrupted in lymphotoxin-deficient mice, normal architecture was rest
197 one in the evolution of the highly organized lymphotoxin dependent B and T white pulp areas within wh
199 ta containing SFB occurred in the absence of lymphotoxin-dependent lymphoid structures and the spleen
200 Previous studies showed that homologous to lymphotoxin, exhibits inducible expression, competes wit
201 at a T cell-restricted ligand, homologous to lymphotoxin, exhibits inducible expression, competes wit
202 The TNF superfamily member homologous to lymphotoxins, exhibits inducible expression, and compete
203 The TNF-related ligand, LIGHT (homologous to lymphotoxins, exhibits inducible expression, and compete
204 ber 14 [TNFSF14; also known as homologous to lymphotoxins, exhibits inducible expression, and compete
205 (TNFSF14, also known as LIGHT [homologous to lymphotoxins, exhibits inducible expression, and compete
209 imulation in wild-type B cells, elevation of lymphotoxin expression in grb2(-/-) B cells is only indu
210 Peripheral lung homeostatic chemokine and lymphotoxin expression were visualized by immunostaining
211 Baffr(-) (/) (-) animals resulted in limited lymphotoxin expression, which is critical for maintenanc
214 +CD11c+ haematopoietic population expressing lymphotoxin has an important role in the formation of Pe
215 on required the cytokines interleukin-22 and lymphotoxin in a commensal bacteria-dependent and -indep
219 hey also expressed high levels of CXCL13 and lymphotoxins known to support lymphoid organogenesis.
220 is process is dependent on the expression of lymphotoxin ligands by host cells, but not by the transf
221 ) was used to evaluate the importance of the lymphotoxin/LIGHT axis in the development and perpetuati
222 gnatures, and differential dependency on the lymphotoxin/LIGHT signaling axis that help to interpret
229 cells, derived from either FasL or TNF-alpha/lymphotoxin (LT) alpha double knockout mice, showed that
231 B cells were absolutely required to provide lymphotoxin (LT) alpha1beta2, which maintained a protect
232 investigating Ly49e promoter activities and lymphotoxin (LT) alphabeta dependency in resting versus
234 d the roles of different cellular sources of lymphotoxin (LT) and the adaptive immune response in lym
238 d require constitutive signaling through the lymphotoxin (LT) beta receptor to be maintained in a ful
240 show that Tregs but not non-Treg T cells use lymphotoxin (LT) during migration from allograft to drai
242 conditional gene deficiencies, we found that lymphotoxin (LT) from innate cells expressing transcript
244 ilar to PP formation, ILF formation requires lymphotoxin (LT)- and LT beta receptor-dependent events.
246 into T- and B-cell zones, and expression of lymphotoxin (LT)-alpha, LT-beta, and lymphoid chemokines
247 Here, we demonstrate that DCs express the lymphotoxin (LT)-beta receptor (LT beta R) and that in m
248 onical NF-kappaB pathways by ligation of the lymphotoxin (LT)-beta receptor (LTbetaR) plays a crucial
249 lated by positive growth signals through the lymphotoxin (LT)-beta receptor; however, the countering
253 a mouse model of human AIP by overexpressing lymphotoxin (LT)alpha and beta specifically in acinar ce
255 KT1(a) subset are selectively dependent upon lymphotoxin (LT)alpha1beta2-LTbeta receptor-dependent di
265 we report that IL-22 acted downstream of the lymphotoxin pathway and regulated the organization and m
267 herefore, input from both Th17 cells and the lymphotoxin pathway induce the formation of an immune-co
269 tiple organs, provoking speculation that the lymphotoxin pathway may play a role in central tolerance
270 nals, which suggests that IL-22 connects the lymphotoxin pathway to mucosal epithelial defense mechan
274 or on T cells (LIGHT), signaling through the lymphotoxin receptor (LTbetaR) expressed on mature hepat
276 r ligand for herpes virus entry mediator and lymphotoxin receptor)/herpes simplex virus entry mediato
277 Blockade of germinal center formation with a lymphotoxin-receptor-immunoglobulin fusion protein suppr
278 ymphotoxin-beta receptor (LTbetaR) by LIGHT (lymphotoxin-related inducible ligand that competes for g
280 complex with its known ligands homologous to lymphotoxin, showing inducible expression, and competing
281 wn ligands include Fas ligand, homologous to lymphotoxin, showing inducible expression, and competing
282 nation of Fas.Fc, LT-betaR.Fc (homologous to lymphotoxin, showing inducible expression, and competing
283 SF14 [LIGHT (name derived from homologous to lymphotoxins, shows inducible expression, and competes w
288 Indeed, a series of reports has claimed that lymphotoxin signals control the expression of Aire, a tr
290 infection with C. rodentium in mice lacking lymphotoxin signals, which suggests that IL-22 connects
294 system that involves proinflammatory ligand, lymphotoxin that exhibits inducible expression and compe
295 tory factor (MIF), and tumor necrosis factor/lymphotoxin (TNF/LT), each of which significantly contri
297 re model of M cell differentiation, we found lymphotoxin/tumor necrosis factor alpha induction of CD1
299 trate-resistant prostate cancer by producing lymphotoxin, which activates an IkappaB kinase alpha (IK
300 ates and induced lung B cells to up-regulate lymphotoxin, which further promoted CXCL13 production, e
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。